Cite
HARVARD Citation
Saini, L. et al. (n.d.). The fludarabine, cytarabine, and granulocyte colony‐stimulating factor (FLAG) chemotherapy regimen is an alternative to anthracycline‐based therapy for the treatment of acute myeloid leukemia for patients with pre‐existing cardiac disease. European journal of haematology. pp. 471-478. [Online].